US Stock MarketDetailed Quotes

COCH Envoy Medical

Watchlist
  • 1.530
  • +0.100+6.99%
Close Mar 17 16:00 ET
32.58MMarket Cap-1.00P/E (TTM)

Envoy Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-355.41%-2.81M
-21.67%-4.91M
-94.15%-5.85M
-100.50%-17.65M
-392.14%-11.71M
144.35%1.1M
-4.03M
-3.01M
-26.95%-8.81M
-2.38M
Net income from continuing operations
-504.89%-5.96M
70.20%-3.95M
52.69%-6.27M
-87.83%-29.91M
57.47%-4.88M
209.93%1.47M
---13.25M
---13.25M
-83.55%-15.92M
---11.48M
Operating gains losses
419.05%737K
---1.05M
1,184.62%1.34M
-5,362.86%-1.84M
-14,391.67%-1.72M
---231K
--0
--104K
3,400.00%35K
--12K
Depreciation and amortization
68.97%49K
44.83%42K
25.93%34K
77.33%133K
84.62%48K
31.82%29K
--29K
--27K
5.63%75K
--26K
Other non cash items
127.76%1.33M
-107.69%-676K
-99.67%31K
86.50%13.45M
-99.65%30K
-778.68%-4.78M
--8.8M
--9.4M
312.41%7.21M
--8.6M
Change In working capital
-74.78%1.16M
3.33%403K
-263.77%-1.19M
-498.75%-958K
-1,460.41%-6.67M
817.50%4.59M
--390K
--726K
-95.12%-160K
--490K
-Change in receivables
50.00%-27K
195.00%19K
316.67%25K
-536.17%-205K
-344.64%-137K
---54K
---20K
--6K
347.37%47K
--56K
-Change in inventory
287.96%203K
-5,100.00%-300K
---140K
94.85%-10K
187.50%92K
28.00%-108K
--6K
--0
-452.73%-194K
--32K
-Change in prepaid assets
188.76%624K
159.38%76K
-16.22%-43K
-2,278.95%-828K
-46.67%40K
-511.30%-703K
---128K
---37K
265.22%38K
--75K
-Change in payables and accrued expense
-76.63%1.3M
-120.97%-138K
-219.09%-998K
-3.79%457K
-906.71%-6.62M
1,730.41%5.58M
--658K
--838K
541.89%475K
--820K
-Change in other current liabilities
-694.12%-945K
692.06%746K
59.26%-33K
29.28%-372K
90.67%-46K
-260.61%-119K
---126K
---81K
-211.24%-526K
---493K
Cash from discontinued investing activities
Operating cash flow
-355.41%-2.81M
-21.67%-4.91M
-94.15%-5.85M
-100.50%-17.65M
-392.14%-11.71M
144.35%1.1M
---4.03M
---3.01M
-26.95%-8.81M
---2.38M
Investing cash flow
Cash flow from continuing investing activities
-891.94%-615K
-7,081.82%-790K
-84.75%-109K
29.82%-153K
48.78%-21K
18.42%-62K
-11K
-59K
-74.40%-218K
-41K
Net PPE purchase and sale
-891.94%-615K
-7,081.82%-790K
-84.75%-109K
29.82%-153K
48.78%-21K
18.42%-62K
---11K
---59K
-74.40%-218K
---41K
Cash from discontinued investing activities
Investing cash flow
-891.94%-615K
-7,081.82%-790K
-84.75%-109K
29.82%-153K
48.78%-21K
18.42%-62K
---11K
---59K
-74.40%-218K
---41K
Financing cash flow
Cash flow from continuing financing activities
-61.23%6.1M
-16.67%2.5M
67.08%6.68M
169.96%21.85M
-144.55%-891K
408.93%15.74M
3M
4M
0.42%8.09M
2M
Net issuance payments of debt
150.00%7.5M
-16.67%2.5M
25.00%5M
25.00%10M
--0
0.00%3M
--3M
--4M
0.00%8M
--2M
Net common stock issuance
--0
--0
--1.68M
--109K
--109K
--0
--0
--0
--0
----
Net preferred stock issuance
----
----
----
--11.74M
---1M
----
----
----
--0
--0
Proceeds from stock option exercised by employees
----
----
----
--0
--0
----
----
----
58.62%92K
--0
Cash from discontinued financing activities
Financing cash flow
-61.23%6.1M
-16.67%2.5M
67.08%6.68M
169.96%21.85M
-144.55%-891K
408.93%15.74M
--3M
--4M
0.42%8.09M
--2M
Net cash flow
Beginning cash position
2,467.65%1.75M
343.90%4.95M
2,204.92%4.22M
-83.68%183K
2,665.19%16.84M
-5.56%68K
--1.11M
--183K
736.57%1.12M
--609K
Current changes in cash
-84.03%2.68M
-206.03%-3.2M
-21.72%728K
533.73%4.04M
-2,904.76%-12.62M
3,017.66%16.77M
---1.05M
--930K
-193.38%-931K
---420K
Effect of exchange rate changes
0.00%-1K
0.00%-1K
-200.00%-1K
57.14%-3K
66.67%-2K
---1K
---1K
--1K
30.00%-7K
---6K
End cash Position
-73.73%4.42M
2,467.65%1.75M
343.90%4.95M
2,204.92%4.22M
2,204.92%4.22M
2,665.19%16.84M
--68K
--1.11M
-83.68%183K
--183K
Free cash flow
-429.99%-3.42M
-40.87%-5.7M
-93.97%-5.96M
-97.35%-17.81M
-384.67%-11.73M
140.60%1.04M
---4.05M
---3.07M
-27.79%-9.02M
---2.42M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -355.41%-2.81M-21.67%-4.91M-94.15%-5.85M-100.50%-17.65M-392.14%-11.71M144.35%1.1M-4.03M-3.01M-26.95%-8.81M-2.38M
Net income from continuing operations -504.89%-5.96M70.20%-3.95M52.69%-6.27M-87.83%-29.91M57.47%-4.88M209.93%1.47M---13.25M---13.25M-83.55%-15.92M---11.48M
Operating gains losses 419.05%737K---1.05M1,184.62%1.34M-5,362.86%-1.84M-14,391.67%-1.72M---231K--0--104K3,400.00%35K--12K
Depreciation and amortization 68.97%49K44.83%42K25.93%34K77.33%133K84.62%48K31.82%29K--29K--27K5.63%75K--26K
Other non cash items 127.76%1.33M-107.69%-676K-99.67%31K86.50%13.45M-99.65%30K-778.68%-4.78M--8.8M--9.4M312.41%7.21M--8.6M
Change In working capital -74.78%1.16M3.33%403K-263.77%-1.19M-498.75%-958K-1,460.41%-6.67M817.50%4.59M--390K--726K-95.12%-160K--490K
-Change in receivables 50.00%-27K195.00%19K316.67%25K-536.17%-205K-344.64%-137K---54K---20K--6K347.37%47K--56K
-Change in inventory 287.96%203K-5,100.00%-300K---140K94.85%-10K187.50%92K28.00%-108K--6K--0-452.73%-194K--32K
-Change in prepaid assets 188.76%624K159.38%76K-16.22%-43K-2,278.95%-828K-46.67%40K-511.30%-703K---128K---37K265.22%38K--75K
-Change in payables and accrued expense -76.63%1.3M-120.97%-138K-219.09%-998K-3.79%457K-906.71%-6.62M1,730.41%5.58M--658K--838K541.89%475K--820K
-Change in other current liabilities -694.12%-945K692.06%746K59.26%-33K29.28%-372K90.67%-46K-260.61%-119K---126K---81K-211.24%-526K---493K
Cash from discontinued investing activities
Operating cash flow -355.41%-2.81M-21.67%-4.91M-94.15%-5.85M-100.50%-17.65M-392.14%-11.71M144.35%1.1M---4.03M---3.01M-26.95%-8.81M---2.38M
Investing cash flow
Cash flow from continuing investing activities -891.94%-615K-7,081.82%-790K-84.75%-109K29.82%-153K48.78%-21K18.42%-62K-11K-59K-74.40%-218K-41K
Net PPE purchase and sale -891.94%-615K-7,081.82%-790K-84.75%-109K29.82%-153K48.78%-21K18.42%-62K---11K---59K-74.40%-218K---41K
Cash from discontinued investing activities
Investing cash flow -891.94%-615K-7,081.82%-790K-84.75%-109K29.82%-153K48.78%-21K18.42%-62K---11K---59K-74.40%-218K---41K
Financing cash flow
Cash flow from continuing financing activities -61.23%6.1M-16.67%2.5M67.08%6.68M169.96%21.85M-144.55%-891K408.93%15.74M3M4M0.42%8.09M2M
Net issuance payments of debt 150.00%7.5M-16.67%2.5M25.00%5M25.00%10M--00.00%3M--3M--4M0.00%8M--2M
Net common stock issuance --0--0--1.68M--109K--109K--0--0--0--0----
Net preferred stock issuance --------------11.74M---1M--------------0--0
Proceeds from stock option exercised by employees --------------0--0------------58.62%92K--0
Cash from discontinued financing activities
Financing cash flow -61.23%6.1M-16.67%2.5M67.08%6.68M169.96%21.85M-144.55%-891K408.93%15.74M--3M--4M0.42%8.09M--2M
Net cash flow
Beginning cash position 2,467.65%1.75M343.90%4.95M2,204.92%4.22M-83.68%183K2,665.19%16.84M-5.56%68K--1.11M--183K736.57%1.12M--609K
Current changes in cash -84.03%2.68M-206.03%-3.2M-21.72%728K533.73%4.04M-2,904.76%-12.62M3,017.66%16.77M---1.05M--930K-193.38%-931K---420K
Effect of exchange rate changes 0.00%-1K0.00%-1K-200.00%-1K57.14%-3K66.67%-2K---1K---1K--1K30.00%-7K---6K
End cash Position -73.73%4.42M2,467.65%1.75M343.90%4.95M2,204.92%4.22M2,204.92%4.22M2,665.19%16.84M--68K--1.11M-83.68%183K--183K
Free cash flow -429.99%-3.42M-40.87%-5.7M-93.97%-5.96M-97.35%-17.81M-384.67%-11.73M140.60%1.04M---4.05M---3.07M-27.79%-9.02M---2.42M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------

Trending Stocks

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More